Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian L Henry

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|October 16, 2008
Recent research developments in the direct inhibition of coagulation proteinases--inhibitors of the initiation phaseBrian L Henry, Umesh R Desai
Thrombosis Research|September 23, 2014
Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparinBrian L Henry, Umesh R Desai
Expert Opinion on Drug Discovery|June 3, 2014
Discovery methodology for the development of direct factor VIIa inhibitorsBrian L Henry, Umesh R Desai
Reviews in Cardiovascular Medicine|September 27, 2016
A Review of the Clinical Subgroup Analyses From the RE-LY TrialRohit Kumar, Aref M Rahman, Brian L Henry
Journal of Intensive Care Medicine|July 10, 2014
Authors' ResponseBrian L Henry, Rohit Kumar, Roy E Smith
Journal of Intensive Care Medicine|March 27, 2014
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital ExperienceRohit Kumar, Roy E Smith, Brian L Henry
Journal of the American College of Cardiology|July 4, 2015
Mode of Death Prevention by SerelaxinBrian L Henry, David S Schwartzman, Guy Salama
Clinical Nephrology. Case Studies|October 19, 2017
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal functionThin Thin Maw, Brian L Henry, Tripti Singh
Biochemical and Biophysical Research Communications|December 14, 2011
Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteasesBrian L Henry, Jay N Thakkar, Aiye Liang, et al.
Thrombosis and Haemostasis|December 22, 2009
Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologiesBrian L Henry, May Abdel Aziz, Qibing Zhou, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cardiovascular & Hematological Agents in Medicinal Chemistry|October 16, 2008
Recent research developments in the direct inhibition of coagulation proteinases--inhibitors of the initiation phaseBrian L Henry, Umesh R Desai
Thrombosis Research|September 23, 2014
Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparinBrian L Henry, Umesh R Desai
Expert Opinion on Drug Discovery|June 3, 2014
Discovery methodology for the development of direct factor VIIa inhibitorsBrian L Henry, Umesh R Desai
Reviews in Cardiovascular Medicine|September 27, 2016
A Review of the Clinical Subgroup Analyses From the RE-LY TrialRohit Kumar, Aref M Rahman, Brian L Henry
Journal of Intensive Care Medicine|July 10, 2014
Authors' ResponseBrian L Henry, Rohit Kumar, Roy E Smith
Journal of Intensive Care Medicine|March 27, 2014
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital ExperienceRohit Kumar, Roy E Smith, Brian L Henry
Journal of the American College of Cardiology|July 4, 2015
Mode of Death Prevention by SerelaxinBrian L Henry, David S Schwartzman, Guy Salama
Clinical Nephrology. Case Studies|October 19, 2017
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal functionThin Thin Maw, Brian L Henry, Tripti Singh
Biochemical and Biophysical Research Communications|December 14, 2011
Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteasesBrian L Henry, Jay N Thakkar, Aiye Liang, et al.
Thrombosis and Haemostasis|December 22, 2009
Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologiesBrian L Henry, May Abdel Aziz, Qibing Zhou, et al.
Pageof 2